The board of directors of JD Health International Inc. announced the below changes to the Board and the composition of the Board committee. The Board announced that Ms. Pang Zhang has tendered her resignation as a non-executive Director and a member of the remuneration committee of the company, with effect from September 6, 2021 due to her other business engagements which require more of her time and dedication. The Board announced that Mr. Enlin Jin has been appointed as an executive Director of the company, with effect from September 6, 2021. Mr. Enlin has extensive experience in pharmaceuticals and TMT industry. He serves as the vice president at JD.com Inc. The Board further announced that Mr. Lijun Xin has been re-designated from an executive Director of the company to a non-executive Director, with effect from September 6, 2021. Lijun Xin, was appointed as the executive Director and the chief executive of icer of the Group on June 28, 2019. The Board further announced that Ms. Sandy Ran a non-executive Director, has been appointed as a member of the Remuneration Committee, with effect from September 6, 2021.